Image

North America Drug-Device Combination Market – Industry Trends and Forecast to 2028

Healthcare

Image

North America Drug-Device Combination Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Oct 2021
  • North America
  • 350 Pages
  • No of Tables: 21
  • No of Figures: 43

North America Drug-Device Combination Market, By Product (Auto-Injector, Microneedle Patch, Digital Pill, Smart Inhaler, Drug Delivery Hydrogels, Drug-Eluting Lens and Others), Application Type (Orthopedic Diseases, Respiratory Diseases, DiabetesOncologyCardiovascular Diseases and Others), End User (Clinics, Hospitals, Home Care Settings, Ambulatory Care Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast To 2028.

North America Drug-Device Combination Market

Market Analysis and Insights: North America Drug-Device Combination Market

Drug-Device combination market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.9% in the forecast period of 2021 to 2028 and is expected to reach USD 17,843.53 million by 2028 from USD 8,086.79 million in 2020. Increasing usage of drug-device combination products, growing incidence of COVID-19 are the major drivers which propelled the demand of the market in the forecast period.

The increasing prevalence of chronic disease advancement in technology effectively help the growth of the drug-device combination market. However, the limitations and complications associated with the Drug-Device combination may hamper the future development of medical devices market. The partnerships and collaborations by significant market players act as opportunities for the growth of the global drug-device combination market.

The drug-device combination market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Drug-Device Combination MarketNorth America Drug-Device Combination Market Scope and Market Size

Drug-device combination market is segmented on the basis of product, application, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the drug-device combination market is segmented into auto-injector, microneedle patch, digital pill, smart inhaler, drug delivery hydrogels, drug-eluting lens, and others. Auto-injector is further sub-segmented into wearable auto-injector, hand-held auto-injector. In 2021, auto-injector holds highest share in the drug-device combination market as large number of patient pool suffering from chronic diseases.
  • On the basis of application, the global drug-device combination market is segmented into orthopedic diseases, respiratory diseases, diabetes, oncology, cardiovascular diseases, and others. In 2021, the orthopedic is expected to dominate the drug-device combination market due to the growing number of surgeries. Moreover, an initiative by the government anticipated propelling the further market growth.
  • On the basis of end users, the drug-device combination market is segmented into clinics, hospitals, home care settings, ambulatory care centers, and others. In 2021, the clinics are expected to dominate the drug-device combination market because most patients are suffering from chronic diseases, so they would be seen in the clinics to get proper regular check-ups, treatment and management. Moreover, due to COVID-19, most patients do not prefer to visit hospitals in fear of infection.
  • On the basis of distribution channel, the drug-device combination market is segmented into direct tender, retail sales, and others. In 2021, the direct tender is expected to dominate the drug-device combination market due to having complete control over the sales and revenue process as well as direct interaction with your customers. The segment is growing due to increasing number of hospitals in developed as well as developing  countries.

North America Drug-Device Combination MarketDrug-Device Combination Market Country Level Analysis

The drug-device combination market is analysed, and market size information is provided by product, application type, end user, and distribution channel. The countries covered in the drug-device combination market report are the U.S., Canada, and Mexico.  

North America is expected to dominate the market due to the high adoption of drug-device combination products by the patients in the region. U.S is dominating in the market and leading the growth in the North America market due to increased presence of key market players in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Increasing Collaborations and Partnerships in Drug-Device Combination Market is Creating New Opportunities for Players in the Drug-Device Combination Market  

Drug-Device combination market also provides you with detailed market analysis for every country growth. Additionally, it provides data regarding collaborations and partnerships among the major market plyers and start-up companies. Moreover, the growing impact of research and development activities on drug-device combination market growth pace. The data is available for historic period 2010 to 2019

Competitive Landscape and   Medical devices Market Share Analysis

Drug-Device combination market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to drug-device combination market.

The major players covered in the report Mediprint, OcuMedic, Medtronic, GlaxoSmithKline Plc, BD, Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), Bayer AG, Micron Biomedical, Inc., Otsuka America Pharmaceutical, Inc., VAXXAS, Propeller Health, Raphas Co., Ltd., EOFLOW CO., LTD., Insulet Corporation, TheraJect, Zimmer Biomet, Amgen Inc., Eitan Medical among others domestic and North America players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Growing Collaboration, contract and agreement by key players accelerating the market growth.

For instance,

  • In March 2021, Eitan Medical collaborated with Stevanato for bringing wearable injection solutions to market for the simple and efficient subcutaneous administration of large-volume and high viscosity medications that serve the interests of both patients and pharmaceutical companies. This would strengthen leadership and innovation capabilities globally.
  • In April, EOFlow Co., Ltd. US Subsidiary Nephria got License on new "MXene" Nanomaterial from Drexel University. Nephria got exclusive rights and planned to develop wearable dialysis system, otherwise known as the wearable artificial kidney (WAK), starting with this technology transfer. This would accelerate the technologies in the new therapeutic areas and increases the growth of market.
  • In January 2020, Amgen Inc. announced the successful strategic collaboration with BeiGene. It is predicted that this collaboration enhanced the company’s footprints in China oncology market in the coming years.

Partnerships, joint ventures and other strategies by the market player is enhancing the drug-device combination market growth which also provides the benefit for organisation to improve their offering for better consumer experience.


SKU-

TABLE 1 DRUG-DEVICE COMIBINATION MARKET, PIPELINE ANALYSIS

TABLE 2 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 3 NORTH AMERICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 7 U.S. DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 8 U.S. AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 9 U.S. DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 10 U.S. DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 11 U.S. DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 12 CANADA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 13 CANADA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 14 CANADA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 15 CANADA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 16 CANADA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 17 MEXICO DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 18 MEXICO AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 19 MEXICO DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 20 MEXICO DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 21 MEXICO DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials